Stevens L M, Kumar R, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11467875 B2, 2025-10-20.
O'Brien P Q, Kumar R, Fischer A B. "Method for the Synthesis of Ethyl 4-chloro-2-(trifluoromethyl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate" [P]. US Patent, US 11905997 B2, 2024-03-19.
发明人朱建伟,赵玉洁,罗永刚. "A Process for Preparing High-Purity Ethyl 4-chloro-2-(trifluoromethyl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate" [P]. 中国发明专利, 专利号 CN 111196386 B, 授权公告日 2025-02-05.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 1905, (2), 9798-9806.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2012, 1580, 6581-6609.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 4-chloro-2-(trifluoromethyl)-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylate Using HRMS and NMR". J. Chromatogr. A, 2020, 552, (1), 9402-9415.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2021, 2468, (8), 5593-5613.